Manager PR & Communications Jan Phillip Denkers
Cooperation for faster drug discovery
The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...
Read more …Fighting Chronic Diseases and Cancer
For the study, which has now been published in the journal Antioxidants, the team led by experimental physicist Florian Grüner of the University of Hamburg ...
Read more …Evotec: Collaboration with Bristol Myers Squibb
Evotec SE announced that its collaboration with Bristol Myers Squibb has been expanded to include a new cell type, triggering a payment of $ 9.0 ...
Read more …Evotec & Takeda: strategic RNA alliance
Evotec SE today announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover ...
Read more …Indivumed Announces Expansion
Indivumed GmbH (“Indivumed”) announced today the founding of Ix Therapeutics GmbH (“Ix Therapeutics”), a joint venture with Xlife Sciences AG (“Xlife Sciences”), which marks Indivumed’s ...
Read more …FBRI and Fraunhofer IME: Research Agreement with Japanese company
As part of their long term co-operation the Foundation for Biomedical Research and Innovation at Kobe (FBRI), the Fraunhofer ...
Read more …Just - Evotec produce antibody products against COVID-19
Evotec SE today announced that the U.S. Department of Defense (“DOD”) awarded its Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to ...
Read more …BMBF funds MS-project with 1.2 million Euro
The University Medical Center Hamburg-Eppendorf (UKE) and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME want to pave the way for new therapies ...
Read more …Just-Evotec Biologics partners with ABL against HIV
Evotec SE today announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into an agreement with Advanced BioScience Laboratories, Inc. (“ABL”), a ...
Read more …